←Back to Expert Scholars
Translational Medicine / 转化医学KRAS Combination Therapy
Grace Dy
MD
🏢Roswell Park Comprehensive Cancer Center🌐USA
Chief of Thoracic Oncology
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Grace Dy contributed to pivotal trials of adagrasib in KRAS G12C mutant lung cancer and is advancing combination studies with anti EGFR and other agents. Her work supports expansion of KRAS targeted combinations across lines of therapy. She leads academic clinical research at Roswell Park.
Share:
🧪Research Fields 研究领域
lung cancer
KRAS G12C
adagrasib
clinical trials
combination therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Grace Dy 的研究动态
Follow Grace Dy's research updates
留下邮箱，当我们发布与 Grace Dy（Roswell Park Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment